Drug: vincristine Quarter: 2016Q3
Total Records: 1,179 Number of Pages: 59
| DRUGNAME | PT | EventCount |
|---|---|---|
| VINCRISTINE SULFATE. | Erythema | 3 |
| VINCRISTINE SULFATE. | Fatigue | 3 |
| VINCRISTINE SULFATE. | Feeling abnormal | 3 |
| VINCRISTINE SULFATE. | Gait disturbance | 3 |
| VINCRISTINE SULFATE. | Gallbladder necrosis | 3 |
| VINCRISTINE SULFATE. | Generalised tonic-clonic seizure | 3 |
| VINCRISTINE SULFATE. | Haemoglobin decreased | 3 |
| VINCRISTINE SULFATE. | Hepatotoxicity | 3 |
| VINCRISTINE SULFATE. | Histiocytosis haematophagic | 3 |
| VINCRISTINE SULFATE. | Intestinal ischaemia | 3 |
| VINCRISTINE SULFATE. | Jaundice | 3 |
| VINCRISTINE SULFATE. | Loss of consciousness | 3 |
| VINCRISTINE SULFATE. | Lung infection | 3 |
| VINCRISTINE SULFATE. | Multiple-drug resistance | 3 |
| VINCRISTINE SULFATE. | Myelodysplastic syndrome | 3 |
| VINCRISTINE SULFATE. | Neoplasm malignant | 3 |
| VINCRISTINE SULFATE. | Neutrophil count decreased | 3 |
| VINCRISTINE SULFATE. | Pain | 3 |
| VINCRISTINE SULFATE. | Pallor | 3 |
| VINCRISTINE SULFATE. | Pathogen resistance | 3 |
Total Records: 1,179 Number of Pages: 59